Rapamycin inhibits oral cancer cell growth by promoting oxidative stress and suppressing ERK1/2, NF-κB and beta-catenin pathways

por Semlali, Abdelhabib, Papadakos, Sofia, Contant, Camille, Zouaoui, Ikram, Rouabhia, Mahmoud
Publicado 2022